Header Logo

Connection

Naoko Takebe to Hydroxylamines

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Hydroxylamines.
Naoko Takebe
Connection Strength
0.060
Hydroxylamines
  1. Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clin Cancer Res. 2024 Aug 01; 30(15):3167-3178.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.